Private company
Fabre-Kramer
Logo: previous employee, CC BY-SA 2.5, via Wikimedia Commons3
Fabre-Kramer Pharmaceuticals is a pharmaceutical company that specializes in the development of psychotropic drugs. Products in their current development pipeline include gepirone and FKB01MD for major depression, gepirone and FKW00GA for social anxiety disorder, gepirone for hypoactive sexual desire disorder, FKF02SC for schizophrenia, and FKK01PD for Parkinson's disease. The company has also conducted clinical studies on a gepirone extended release formulation for major depression.2 It was founded in 1992.1 Wikipedia text CC BY-SA 4.0
Last updated Oct 21, 2026.
Overview
- Industrypharmaceutical industry1
- Websitewww.fabrekramer.com
See how the biggest companies compare on our leaderboards
Fabre-Kramer Pharmaceuticals is a pharmaceutical company that specializes in the development of psychotropic drugs. Products in their current development pipeline include gepirone and FKB01MD for major depression, gepirone and FKW00GA for social anxiety disorder, gepirone for hypoactive sexual desire disorder, FKF02SC for schizophrenia, and FKK01PD for Parkinson's disease.2
Timeline
- 1992Founded Founded1
Links
- Websitewww.fabrekramer.com1
- WikipediaFabre-Kramer Pharmaceuticals
- WikidataQ5427962
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1WikidataFabre-Kramer on Wikidata
- 2WikipediaFabre-Kramer on Wikipedia
- 3Wikimedia CommonsFabre-Kramer logo by previous employee, CC BY-SA 2.5